HUTCHMED (China) Limited (0013.HK)

HKD 23.0

(-0.22%)

Inventory Summary of HUTCHMED (China) Limited

  • HUTCHMED (China) Limited's latest annual inventory in 2023 was 50.25 Million USD , down -11.35% from previous year.
  • HUTCHMED (China) Limited's latest quarterly inventory in 2024 Q1 was 46.44 Million USD , down -7.59% from previous quarter.
  • HUTCHMED (China) Limited reported annual inventory of 56.69 Million USD in 2022, up 58.55% from previous year.
  • HUTCHMED (China) Limited reported annual inventory of 35.75 Million USD in 2021, up 80.89% from previous year.
  • HUTCHMED (China) Limited reported quarterly inventory of 46.44 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported quarterly inventory of 53.87 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of HUTCHMED (China) Limited (2023 - 2005)

Historical Annual Inventory of HUTCHMED (China) Limited (2023 - 2005)

Year Inventory Inventory Growth
2023 50.25 Million USD -11.35%
2022 56.69 Million USD 58.55%
2021 35.75 Million USD 80.89%
2020 19.76 Million USD 21.95%
2019 16.2 Million USD 31.68%
2018 12.3 Million USD 4.41%
2017 11.78 Million USD -8.06%
2016 12.82 Million USD 34.19%
2015 9.55 Million USD 116.91%
2014 4.4 Million USD 210.21%
2013 1.42 Million USD -94.39%
2012 25.31 Million USD -11.84%
2011 28.71 Million USD 7.84%
2010 26.63 Million USD 52.39%
2009 17.47 Million USD 18.76%
2008 14.71 Million USD 25.52%
2007 11.72 Million USD 23.52%
2006 9.49 Million USD 9.37%
2005 8.67 Million USD 0.0%

Peer Inventory Comparison of HUTCHMED (China) Limited

Name Inventory Inventory Difference
Pak Fah Yeow International Limited 12.19 Million HKD -312.052%
Grand Pharmaceutical Group Limited 1.38 Billion HKD 96.381%
Extrawell Pharmaceutical Holdings Limited 7.26 Million HKD -591.783%
Wai Yuen Tong Medicine Holdings Limited 308.09 Million HKD 83.688%
Qianhai Health Holdings Limited 431.78 Million HKD 88.36%
Lee's Pharmaceutical Holdings Limited 298.1 Million HKD 83.141%
Essex Bio-Technology Limited 62.82 Million HKD 19.999%
Tongfang Kontafarma Holdings Limited 98.26 Million HKD 48.855%
PuraPharm Corporation Limited 175.59 Million HKD 71.379%
SSY Group Limited 1.08 Billion HKD 95.373%
JBM (Healthcare) Limited 91.58 Million HKD 45.124%
Jacobson Pharma Corporation Limited 317.85 Million HKD 84.188%
China Resources Pharmaceutical Group Limited 35.09 Billion HKD 99.857%